Foreign-Trade Zone 177-Evansville, Indiana, Application for Subzone, Pfizer Inc., (Pharmaceutical Products), Terre Haute, IN, 20645 [E6-6020]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 77 / Friday, April 21, 2006 / Notices
NPA: Morgan Memorial Goodwill Industries,
Boston, Massachusetts.
Contracting Activity: GSA, Region 1, Boston,
Massachusetts.
G. John Heyer,
General Counsel.
[FR Doc. E6–6015 Filed 4–20–06; 8:45 am]
BROADCASTING BOARD OF
GOVERNORS
Sunshine Act Meeting
Tuesday, April 25, 2006,
2–3 p.m.
Radio Free Asia, Conference
Room, 2025 M Street, NW., Washington,
DC 20036.
PLACE:
CLOSED MEETING: The members of the
Broadcasting Board of Governors (BBG)
will meet in closed session to review
and discuss a number of issues relating
to U.S. Government-funded nonmilitary international broadcasting.
They will address internal procedural,
budgetary, and personnel issues, as well
as sensitive foreign policy issues
relating to potential options in the U.S.
international broadcasting field. This
meeting is closed because if open it
likely would either disclose matters that
would be properly classified to be kept
secret in the interest of foreign policy
under the appropriate executive order (5
U.S.C. 552b(c)(1) or would disclose
information the premature disclosure of
which would be likely to significantly
frustrate implementation of a proposed
agency action. (5 U.S.C. 52b(c)(9)(B)). In
addition, part of the discussion will
relate solely to the internal personnel
and organizational issues of the BBG or
the International Broadcasting Bureau.
(5 U.S.C. 552b(c)(2) and (6)).
CONTACT PERSON FOR MORE INFORMATION:
Persons interested in obtaining more
information should contact Carol
Booker at (202) 203–4545.
Dated: April 17, 2006.
Carol Booker,
Legal Counsel.
[FR Doc. 06–3847 Filed 4–19–06; 8:45 am]
rwilkins on PROD1PC63 with NOTICES
BILLING CODE 8230–01–M
VerDate Aug<31>2005
17:44 Apr 20, 2006
Jkt 208001
Foreign–Trade Zones Board
[Docket 14–2006]
Foreign–Trade Zone 177—Evansville,
Indiana, Application for Subzone,
Pfizer Inc., (Pharmaceutical Products),
Terre Haute, IN
BILLING CODE 6353–01–P
DATE AND TIME:
DEPARTMENT OF COMMERCE
An application has been submitted to
the Foreign–Trade Zones Board (the
Board) by the Indiana Port Commission,
grantee of FTZ 177, requesting special
purpose subzone status for the
manufacturing and warehousing
facilities of Pfizer Inc (Pfizer), located in
Terre Haute, Vigo County, Indiana. The
application was submitted pursuant to
the provisions of the Foreign–Trade
Zones Act, as amended (19 U.S.C. 81a–
81u), and the regulations of the Board
(15 CFR part 400). It was formally filed
on April 12, 2006.
The Pfizer facilities consist of three
sites on 532 acres in Terre Haute,
Indiana: Site 1 (27 bldgs. on 521 acres/
386,932 sq. ft., about half of which is
devoted to Exubera manufacturing)
located at 411 East Dallas Road; Site 2
(1 bldg. on 3 acres/61,952 sq. ft.) located
at 1383 Aberdeen Street; and, Site 3 (1
bldg. on 8 acres/45,936 sq. ft.) located at
1650 East Industrial Drive. Site 1 is used
to manufacture pharmaceutical
products. Sites 2 and 3 are used for
warehousing, storage and distribution
activities. Pfizer employees
approximately 340 employees at the
sites.
Pfizer is requesting authority to
manufacture the drug Exubera (HTS
3004.31, duty-free) under zone
procedures. Exubera is an inhaled,
powdered insulin formulation used in
the treatment of diabetes. Initial zone
savings will come from the elimination
of inverted tariffs on the following
components sourced from abroad used
in the production of Exubera:
mannitol (HTS 2905.43, 4.6% duty rate)
which is an inactive ingredient used in
the manufacturing process and base
aluminum foil (HTS 3921.90, 4.2% duty
rate) which is used in packaging the
final product in dosage form.
FTZ procedures would exempt Pfizer
from Customs duty payments on the
foreign components used in export
production. Some 30 percent of the
plant’s initial shipments are to be
exported. On its domestic sales, Pfizer
would be able to choose the duty rates
during Customs entry procedures that
apply to the finished pharmaceutical
product (duty–free) for the foreign
inputs noted above. The request
indicates that the savings generated
from FTZ procedures would help
PO 00000
Frm 00006
Fmt 4703
Sfmt 4703
20645
improve the plant’s international
competitiveness.
In accordance with the Board’s
regulations, a member of the FTZ staff
has been appointed examiner to
investigate the application and report to
the Board.
Public comment is invited from
interested parties. Submissions (original
and 3 copies) shall be addressed to the
Board’s Executive Secretary at one of
the following addresses:
1. Submissions Via Express/Package
Delivery Services: Foreign–Trade Zones
Board, U.S. Department of Commerce,
Franklin Court Building—Suite 4100W,
1099 14th St. NW., Washington, DC
20005: or
2. Submissions Via the U.S. Postal
Service: Foreign–Trade-Zones Board,
U.S. Department of Commerce, FCB Suite 4100W, 1401 Constitution Ave.
NW., Washington, DC 20230.
The closing period for their receipt is
June 20, 2006. Rebuttal comments in
response to material submitted during
the foregoing period may be submitted
during the subsequent 15-day period
July 5, 2006.
A copy of the application and
accompanying exhibits will be available
for public inspection at the Office of the
Foreign–Trade Zones Board’s Executive
Secretary at the first address listed
above, and at the U.S. Department of
Commerce Export Assistance Center,
11405 North Pennsylvania St, Suite 106,
Carmel, IN 46032.
Dated: April 11, 2006.
Dennis Puccinelli,
Executive Secretary.
[FR Doc. E6–6020 Filed 4–20–06; 8:45 am]
BILLING CODE 3510–DS–S
DEPARTMENT OF COMMERCE
International Trade Administration
[A–570–831]
Notice of Extension of Time Limit for
Final Results of Antidumping Duty
Administrative Review and New
Shipper Reviews: Fresh Garlic from
the People’s Republic of China
Import Administration,
International Trade Administration,
Department of Commerce.
EFFECTIVE DATE: April 21, 2006.
FOR FURTHER INFORMATION CONTACT:
Katharine Huang, AD/CVD Operations,
Office 8, Import Administration,
International Trade Administration,
U.S. Department of Commerce, 14th
Street and Constitution Avenue, NW.,
Washington, DC 20230; telephone: (202)
482–1271.
AGENCY:
E:\FR\FM\21APN1.SGM
21APN1
]]>Agencies
[Federal Register Volume 71, Number 77 (Friday, April 21, 2006)]
[Notices]
[Page 20645]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-6020]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[Docket 14-2006]
Foreign-Trade Zone 177--Evansville, Indiana, Application for
Subzone, Pfizer Inc., (Pharmaceutical Products), Terre Haute, IN
An application has been submitted to the Foreign-Trade Zones Board
(the Board) by the Indiana Port Commission, grantee of FTZ 177,
requesting special purpose subzone status for the manufacturing and
warehousing facilities of Pfizer Inc (Pfizer), located in Terre Haute,
Vigo County, Indiana. The application was submitted pursuant to the
provisions of the Foreign-Trade Zones Act, as amended (19 U.S.C. 81a-
81u), and the regulations of the Board (15 CFR part 400). It was
formally filed on April 12, 2006.
The Pfizer facilities consist of three sites on 532 acres in Terre
Haute, Indiana: Site 1 (27 bldgs. on 521 acres/386,932 sq. ft., about
half of which is devoted to Exubera[reg] manufacturing) located at 411
East Dallas Road; Site 2 (1 bldg. on 3 acres/61,952 sq. ft.) located at
1383 Aberdeen Street; and, Site 3 (1 bldg. on 8 acres/45,936 sq. ft.)
located at 1650 East Industrial Drive. Site 1 is used to manufacture
pharmaceutical products. Sites 2 and 3 are used for warehousing,
storage and distribution activities. Pfizer employees approximately 340
employees at the sites.
Pfizer is requesting authority to manufacture the drug Exubera[reg]
(HTS 3004.31, duty-free) under zone procedures. Exubera[reg] is an
inhaled, powdered insulin formulation used in the treatment of
diabetes. Initial zone savings will come from the elimination of
inverted tariffs on the following components sourced from abroad used
in the production of Exubera[reg]: mannitol (HTS 2905.43, 4.6% duty
rate) which is an inactive ingredient used in the manufacturing process
and base aluminum foil (HTS 3921.90, 4.2% duty rate) which is used in
packaging the final product in dosage form.
FTZ procedures would exempt Pfizer from Customs duty payments on
the foreign components used in export production. Some 30 percent of
the plant's initial shipments are to be exported. On its domestic
sales, Pfizer would be able to choose the duty rates during Customs
entry procedures that apply to the finished pharmaceutical product
(duty-free) for the foreign inputs noted above. The request indicates
that the savings generated from FTZ procedures would help improve the
plant's international competitiveness.
In accordance with the Board's regulations, a member of the FTZ
staff has been appointed examiner to investigate the application and
report to the Board.
Public comment is invited from interested parties. Submissions
(original and 3 copies) shall be addressed to the Board's Executive
Secretary at one of the following addresses:
1. Submissions Via Express/Package Delivery Services: Foreign-Trade
Zones Board, U.S. Department of Commerce, Franklin Court Building--
Suite 4100W, 1099 14th St. NW., Washington, DC 20005: or
2. Submissions Via the U.S. Postal Service: Foreign-Trade-Zones
Board, U.S. Department of Commerce, FCB - Suite 4100W, 1401
Constitution Ave. NW., Washington, DC 20230.
The closing period for their receipt is June 20, 2006. Rebuttal
comments in response to material submitted during the foregoing period
may be submitted during the subsequent 15-day period July 5, 2006.
A copy of the application and accompanying exhibits will be
available for public inspection at the Office of the Foreign-Trade
Zones Board's Executive Secretary at the first address listed above,
and at the U.S. Department of Commerce Export Assistance Center, 11405
North Pennsylvania St, Suite 106, Carmel, IN 46032.
Dated: April 11, 2006.
Dennis Puccinelli,
Executive Secretary.
[FR Doc. E6-6020 Filed 4-20-06; 8:45 am]
BILLING CODE 3510-DS-S
